To characterize CAFs, the expression of selected markers, such as α-SMA, vimentin, S100A4, CD90, CD73 and CD105, has been used [28], and up to 14 subpopulations of immunostimulatory CAFs have been identified in HNSCC [29]. This evidence concerns the gene ACTA1 and head and neck squamous cell carcinoma.